Journal of Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases

Frequencies of functional polymorphisms in three pharmacokinetic genes of clinical interest within the admixed Puerto Rican population

Pharmacogenetics of drug-metabolizing enzymes in US Hispanics

A comprehensive survey of models for dissecting local ancestry deconvolution in human genome

Pharmacogenetically driven treatments for alcoholism

A novel admixture-based pharmacogenetic approach to refine warfarin dosing in Caribbean Hispanics

 Impacto da farmacogenética na farmacocinética dos antirretrovíricos em doentes coinfetados por vírus da imunodeficiência humana (VIH) e vírus da hepatite B (VHB) e/ou Vírus da hepatite C (VHC)

O papel da farmacogenética na terapia do HIV

Farmacogenómica aplicada ao tratamento antirretroviral em Portugal

Conjugar a farmacogenética ea monitorização terapêutica de fármacos: uma estratégia na otimização e individualização da farmacoterapia

Sistema HLA y factores farmacogenéticos en la evolución de la infección por VIH-1 en pacientes de Las Palmas de Gran Canaria

Pediatric Infectious Diseases

Investigation of Molecular Mechanisms Regulating Drug-Drug Interactions in Antiretroviral Therapy

Cytochrome P450 CYP2B6 983T> C Polymorphism as Predictor of Nevirapine Hypersensitivity in Botswana Population.

A pharmacist's role in the individualization of treatment of HIV patients

Adverse drug reactions associated with CYP 2B6 polymorphisms in HIV/AIDS-treated patients in Yaoundé, Cameroon

Genotype and allele frequencies of ABCB1 and SLCO1B1 polymorphisms in THAI HIV-infected patients

Important pharmacogenomic aspects in the management of HIV/AIDS

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients

Individualization of antiretroviral therapy-Pharmacogenomic aspect